STOCK TITAN

Tempus AI SEC Filings

TEM NASDAQ

Welcome to our dedicated page for Tempus AI SEC filings (Ticker: TEM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Parsing Tempus AI’s disclosures can feel like wading through genomic data tables and privacy footnotes. The company’s 10-K details algorithm training costs, HIPAA compliance spending, and the revenue split between lab diagnostics and data subscriptions—facts buried deep in legal language. If you have ever searched “Tempus AI SEC filings explained simply” or wondered how to track “Tempus AI insider trading Form 4 transactions,” you know the challenge.

Stock Titan resolves it. Our platform delivers real-time alerts the moment a “Tempus AI quarterly earnings report 10-Q filing” or a sudden “Tempus AI 8-K material events explained” document hits EDGAR. AI-powered summaries translate every section, so understanding Tempus AI SEC documents with AI takes minutes, not hours. Need to spot leadership sentiment? We surface “Tempus AI Form 4 insider transactions real-time” alongside concise context. Looking at compensation? The “Tempus AI proxy statement executive compensation” highlights are pre-tagged.

Investors use these insights to gauge R&D intensity, evaluate data-licensing momentum, and monitor “Tempus AI executive stock transactions Form 4.” Whether you seek a “Tempus AI annual report 10-K simplified” overview or a single line item like cloud-hosting spend, our AI points you there. Key uses include:

  • Compare segment revenue across consecutive 10-Q reports
  • Track insider buying before product launches
  • Review risk-factor updates tied to evolving health-data regulations

Stop scrolling endless PDFs—get “Tempus AI earnings report filing analysis” in plain language, updated the instant Tempus AI posts.

Rhea-AI Summary

Eric P. Lefkofsky, CEO, Chairman, and 10% owner of Tempus AI, executed significant stock sales through controlled entities on June 17-18, 2025, under a pre-established Rule 10b5-1 trading plan.

Key transaction details:

  • Through Gray Media LLC: Sold 50,000 shares at prices ranging $67.31-$71.21, reducing holdings to 9,307,283 shares
  • Through Blue Media LLC: Disposed of 400,000 shares at prices ranging $67.22-$71.16, reducing holdings to 15,427,132 shares

Post-transaction beneficial ownership includes 4,878,837 shares held directly, and indirect holdings through various entities including 10,000,000 shares in Lefkofsky Family 2025 GRAT. All transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on June 14, 2024, demonstrating planned, compliant insider selling activity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Erik Phelps, EVP & Chief Admin & Legal Officer of Tempus AI, executed significant stock sales on June 16, 2025, through a pre-planned Rule 10b5-1 trading arrangement established on September 6, 2024.

The transactions involved a total disposition of 51,317 shares of Class A Common Stock in multiple trades:

  • 29,333 shares at average price of $72.01
  • 11,186 shares at average price of $72.74
  • 8,898 shares at average price of $73.76
  • 1,900 shares at average price of $74.41

Following these transactions, Phelps retains direct beneficial ownership of 97,779 shares. The sales were executed at progressively higher price points ranging from $71.28 to $74.55, suggesting favorable market conditions during the trading window.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 Filing Details - Insider Trading Activity at Tempus AI

On June 16, 2025, Andrew Polovin, EVP and General Counsel of Tempus AI, executed a sale of 1,423 shares of Class A Common Stock at $72.13 per share. The transaction was conducted under a Rule 10b5-1 trading plan established on September 6, 2024.

Following the transaction, Polovin retains direct beneficial ownership of 137,454 shares of Class A Common Stock. Key transaction details:

  • Transaction Type: Sale (S)
  • Total Value: Approximately $102,641
  • Trading Plan: Executed under pre-established 10b5-1 plan
  • Ownership: Direct

This insider sale represents a relatively small portion (approximately 1%) of Polovin's total holdings in the company, suggesting routine portfolio management rather than a significant shift in position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Tempus AI (TEM)?

The current stock price of Tempus AI (TEM) is $66.52 as of June 28, 2025.

What is the market cap of Tempus AI (TEM)?

The market cap of Tempus AI (TEM) is approximately 11.4B.

What is the core focus of Tempus AI Inc?

Tempus AI Inc focuses on unlocking healthcare data from silos and applying advanced AI techniques to deliver personalized, intelligent diagnostics.

How does the Tempus Platform work?

The Tempus Platform integrates disparate healthcare data sources, analyzes them using sophisticated algorithms, and generates actionable insights for more accurate laboratory diagnostics.

What role does artificial intelligence play in Tempus AI's offerings?

Artificial intelligence, including generative AI, is central to Tempus AI's process, enhancing diagnostic interpretations and tailoring lab tests to individual patient profiles.

Who benefits most from Tempus AI's technology?

Healthcare providers, including hospitals and laboratories, benefit by gaining access to integrated data analytics that lead to more informed diagnostic and treatment decisions.

How does Tempus AI address the challenge of data silos in healthcare?

Tempus AI breaks down data silos through a unified platform that consolidates and analyzes data from multiple sources, ensuring comprehensive and accessible clinical insights.

What differentiates Tempus AI from its competitors?

Tempus AI distinguishes itself with its integrated approach to data management and diagnostics, combining advanced AI techniques with a robust platform designed to deliver personalized insights.

How is data security maintained on the Tempus Platform?

The platform incorporates rigorous data management and encryption protocols to ensure that sensitive healthcare data remains secure while being effectively utilized for diagnostic purposes.

What are the key advantages of using intelligent diagnostics?

Intelligent diagnostics provide enhanced accuracy and personalization in lab tests, enabling healthcare providers to develop targeted treatment plans based on comprehensive data analysis.
Tempus AI

NASDAQ:TEM

TEM Rankings

TEM Stock Data

11.37B
94.94M
47.69%
34.24%
8.23%
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States
CHICAGO